Voices in Psoriatic Arthritis CME Best Practices | myCME

AMA PRA Category 1 Credit(s)^TM

.75 CME Expert presentations and audio clips of patient perceptions to customize treatment for patients with psoriatic arthritis. Exp 6/16/22

R.A.P.I.D. Interstitial Lung Disease Case Study | myCME

AMA PRA Category 1 Credit(s)^TM

The R.A.P.I.D.® CME initiative is designed to instruct primary care clinicians in to recognizing and managing rheumatoid arthritis (RA) in their patients.

Adapting and Adjusting: Best Practices for Utilizing Telehealth in Osteoarthritis Management | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

The final installment in this CME Outfitters Snack series on managing OA focuses on best practices for utilizing telehealth, including encouraging patients to maximize mobility in time of isolation, increasing the utilization of video in telehealth and wearable tech, and the consideration of both operative and non-operative measures for treatment.

Adopting a Tailored Approach to Managing Unmet Needs in Osteoarthritis | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

This CME Outfitters Snack focuses on recognizing the complex pathogenesis of OA, applying The Osteoarthritis Research Society International (OARSI) guidelines to non-surgical management, and evaluating emerging data in order to set realistic goals with patients and meet unmet needs in the management of OA.

Seeing Osteoarthritis Management Through a New Mechanistic Lens | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

The second installment of this CME Outfitters Snack series on improving care and outcomes in OA will evaluate emerging treatments in order to address the unmet needs of current OA therapies.

New Biologics in PsA | myCME

AMA PRA Category 1 Credit(s)^TM

Hear expert insights on when to use interleukin inhibitors in the course of psoriatic arthritis.

Immune Pathways in Systemic Lupus Erythematosus (SLE) | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

The first episode of this CMEOCast podcast series on systemic lupus erythematosus (SLE) focuses on the heterogeneity of lupus, including the multiple immune pathways that are active in it and how knowledge of immunopathogenesis has informed drug development.

Safety and Efficacy of Emerging Treatments for SLE | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

The future is bright for patients with lupus, as drug development activities are currently unprecedented. In this CMEOCast podcast episode, expert faculty evaluate the safety and efficacy of emerging therapies.

Shared Decision-Making in the Selection of SLE Treatments | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

The final episode in this CMEOCast podcast series on SLE addresses the impact and burden of SLE on quality of life, the integration of PROs when caring for patients with SLE, and the implementation of best practices for SDM in order to engage patients as partners in their care.

The Role of Janus Kinase (JAK) in Autoimmune Disease | myCME

AMA PRA Category 1 Credit(s)^TM

This activity will provide clinicians with a solid foundation for understanding the pathophysiology of psoriasis along with other autoimmune diseases, how this pathophysiology informs treatment options, and the most recent clinical trial data for current and emerging agents and management recommendations available to guide therapy selection

Utilizing Serological Biomarkers in Assessing the Disease Severity of Rheumatoid Arthritis | myCME

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s), CE for Pharmacists

Educate clinicians who care for patients with RA on the use of serological biomarkers and the guideline-driven assessment of disease severity to determine the appropriate course of disease management.

Strategies for Optimizing Patient Outcomes in Axial Spondyloarthritis | myCME

AMA PRA Category 1 Credit(s)^TM, AAPA Category I CME credit, CNE Contact Hour(s)

A 45 minute, interactive, video-based, online module designed to provide clinicians with up-to-date evidence and practices for overcoming barriers to early and accurate diagnosis and treatment of axial spondyloarthritis (axSpA), including radiographic (ankylosing spondylitis) and nonradiographic axSpA. Dr. Christopher Ritchlin presents a patient case to provide context for a discussion of clinical evidence on biologic therapies and for developing tailored treatment plans for patients with axSpA.